Synergistic effect of angiotensin-converting enzyme and angiotensinogen gene on cardiac hypertrophy

International Journal of Cardiology

Volumn 72, Issue 2, 2000, Pages 151-161

  Kim, Hyo Soo ^a   Lee, Myoung Mook ^a   Oh, Byung Hee ^a   Kim, Kwang Il ^a   Han, Ki Hoon ^a   Park, Sue Kyung ^b   Sohn, Dae Won ^a   Yoo, Keun Young ^b   Park, Young Bae ^a   Choi, Yun Shik ^a   Lee, Young Woo ^a  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

ACE; Angiotensinogen; Left ventricular hypertrophy; Polymorphism

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; ANGIOTENSINOGEN; CARDIOMEGALY; FEMALE; GENOTYPE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 0033972937     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00184-9     Document Type: Article

References (45)

1. Lindpaintner K., Lu W., Niedermajer N., et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 25:1993;133-143.
2. Lindpainter K., Ganten D. The cardiac renin-angiotensin system: a synopsis of current experimental and clinical data. Acta Cardiol. 3:1991;385-397.
3. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res. 73:1993;413-423.
4. Pfeffer M.A., Lamas G.A., Vaughan D.E., Parisi A.F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
5. Liz W., Schoelkens B.A., Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 11:1989;1325-1350.
6. Baker K.M., Aceto J.F. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 259:1990;H610-H618.
7. Kojima M., Shiojima I., Yamazaki T., et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circ Res. 89:1994;2204-2211.
8. Ruzicka M., Yuan B., Leenen F.H.H. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation. 90:1994;484-491.
9. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20:1992;1433.
10. Rigat B., Hubert C., Alhence-Uelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
11. Danser A.H., Schalekamp M.A., Bax W.A., et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 92:1995;1387-1388.
12. Schunkert H., Hense H.W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
13. Iwai N., Ohmichi N., Nakamura Y., Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 90:1994;2622-2628.
14. Lechin M., Quinones M.A., Omran A., et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
15. Uharavi A.U., Lipkowitz M.S., Diamond J.A., Jhang J.S., Philips R.A. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol. 77:1996;1315-1319.
16. Lindpaintner K., Lee M., Larson M.G., et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med. 334:1996;1023-1028.
17. Kupari M., Perola M., Koskinen P., Virolainen J., Karhunen P.J. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol. 267:1994;H1107-H1111.
18. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
19. Hata A., Namikawa C., Sasaki M., et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 93:1994;1285-1287.
20. Ward K., Hata A., Jeunemaitre X., et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 4:1993;59-61.
21. Ishigami T., Umemura S., Iwamoto T., et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 91:1995;951-954.
22. Katsuya T., Koike G., Yee T.W., et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.
23. Rotimi C., Morrison L., Cooper R., et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension. 24:1994;591-594.
24. Caulfield M., Lavender P., Farrall M., et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330:1994;1629-1633.
25. Iwai N., Shimoike H., Ohmichi N., Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 25:1995;688-693.
26. Kamitani A., Rakugi H., Higaki J., et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 25:1995;950-953.
27. Kim H.S., Lee M.M., Oh B.H., et al. Variant angina is not associated with angiotensin I-converting enzyme gene polymorphism but rather with smoking. Coron Artery Dis. 10:1999;227-233.
28. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 1989;9:16-9:19 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Lindpaintner K., Pfeffer M.A., Kreutz R., et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
30. Rautaharju P.M., LaCroix A.Z., Savage D.D., et al. Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the first national health and nutrition examination survey. Am J Cardiol. 62:1988;59-66.
31. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of left ventricle by two-dimensional echocardiography. American Society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
32. Levy D., Anderson K.M., Savage D.D., Kannel W.B., Christiansen J.C., Castelli W.P. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Intern Med. 108:1988;7-13.
33. Perticone F., Ceravilo R., Cosco C., et al. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol. 29:1997;365-369.
34. Barley J., Blackwood A., Carter N.D., et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens. 12:1994;955-957.
35. Mayet J., Chapman N.K.C., Li C., et al. Ethnic differences in the hypertensive heart and 24-h blood pressure profile. Hypertension. 31:1998;1190-1194.
36. Cambien F., Porer O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
37. O'Donnell C.J., Lindpaintner K., Larson M.U., et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation. 97:1998;1766-1772.
38. Fornage M., Almos C.I., Kardia S., et al. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation. 97:1998;1773-1779.
39. Freire M.B.S., Ji L., Onuma T., Orban T., Warram J.H., Krolewski A.S. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension. 31:1998;896-899.
40. Kannel W.B., Gordon T., Castelli W.P., Margolis J.R. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham study. Ann Intern Med. 72:1970;813-822.
41. Sullivan J.M., Vander-Zwaag R.V., El-Zeky F., Ramanathan K.B., Mirvis D.M. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol. 33:1993;508-513.
42. Montgomery H.E., Clarkson P., Dollery C.M., World M., Deanfield J., Talmud P., McEwan J.R., McKenna W.J., Humphries S. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 96:1997;741-747.
43. Prasad N., O'Kane K.P.J., Johnstone H.A., et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q J Med. 87:1994;659-662.
44. Hernandez D., Lacalzada J., Rufino M., et al. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene. Kidney Int. 51:1997;1205-1211.
45. Sasaki M., Oki T., Iuchi A., et al. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens. 14:1996;1403-1408.